Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 6.5T | 4.5T | 4.7T | 4.4T |
Cost of revenue | 5.4T | 3.6T | 3.6T | 3.6T |
Gross profit | 1.1T | 921.4B | 1.1T | 836.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 637.9B | 272.8B | 227.7B | 222.4B |
Other operating expenses | — | 6.6B | 15.5B | 11.6B |
Operating income | 1.1T | 464.1B | 665.7B | 442.9B |
Non operating interest income | ||||
Income | — | 66.0B | 72.2B | 70.7B |
Expense | — | 122.3B | 123.5B | 133.4B |
Other income expense | — | — | — | — |
Pretax income | 452.2B | 366.9B | 437.9B | 484.1B |
Tax provision | 102.4B | 67.7B | 121.0B | 125.0B |
Net income | 349.9B | 299.3B | 316.9B | 359.1B |
Basic EPS | 770.9 | — | 791 | 954 |
Diluted EPS | 770.9 | — | 791 | 954 |
Basic average shares | — | — | 369.3M | 369.4M |
Diluted average shares | — | — | 369.3M | 369.4M |
EBITDA | 1.1T | 694.6B | 1.2T | 910.7B |
Net income from continuing op. | — | 299.3B | 316.9B | 359.1B |
Minority interests | -65.1B | -1.5B | -24.8B | -6.7B |
Preferred stock dividends | — | — | — | — |